Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI‐based staging, causal hypothesis and progression of subjects at risk of Alzheimer's disease: a multicenter study
0
Zitationen
17
Autoren
2025
Jahr
Abstract
The AI-tool demonstrated its usefulness in supporting the clinical treatment of AD patients by assisting with staging, clinical profiling, diagnosis, hypothesis generation for underlying causes, and predicting the risk of progression to AD-related dementia within 24 months.
Ähnliche Arbeiten
The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research
1989 · 33.647 Zit.
Clinical diagnosis of Alzheimer's disease
1984 · 27.892 Zit.
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 · 24.540 Zit.
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 · 20.643 Zit.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 · 18.490 Zit.
Autoren
- Simona Aresta
- Raffaello Nemni
- Moreno Zanardo
- G. Sirabian
- Dario Capelli
- Marco Alì
- Paolo Vitali
- Enrico Giuseppe Bertoldo
- Valentina Fiolo
- Lilla Bonanno
- Giuseppa Maresca
- Petronilla Battista
- Mark E. Schweitzer
- Francesca B. Pizzini
- Isabella Castiglioni
- Christian Salvatore
- The Alzhemer's Disease Neuroimaging Initiative (ADNI)
Institutionen
- Istituto Universitario di Studi Superiori di Pavia(IT)
- Istituti Clinici Scientifici Maugeri(IT)
- Centro Diagnostico Italiano(IT)
- University of Milan(IT)
- IRCCS Policlinico San Donato(IT)
- Centro Neurolesi Bonino Pulejo(IT)
- University of Verona(IT)
- University of Milano-Bicocca(IT)
- Alzheimer’s Disease Neuroimaging Initiative(US)